50 related articles for article (PubMed ID: 278886)
1. Charcoal-induced lipid reduction in uremia.
Friedman EA; Feinstein EI; Beyer MM; Galonsky RS; Hirsch SR
Kidney Int Suppl; 1978 Jun; (8):S170-6. PubMed ID: 278886
[TBL] [Abstract][Full Text] [Related]
2. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
3. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
[TBL] [Abstract][Full Text] [Related]
4. [Results of a multicenter study on the effect on serum triglycerides and cholesterol administration of carnitine in chronic uremia patients undergoing periodic hemodialysis treatment].
Toigo G; Situlin R; Dardi F; Bazzato G; Vasile A; Tesio F; Ciman M; Guarnieri GF
G Clin Med; 1982; 63(11-12):841-9. PubMed ID: 7182204
[No Abstract] [Full Text] [Related]
5. Serum lipids in uraemic patients on regular haemodialysis.
Pierides AM; Weightman D; Goldfinch M; Tsoukantas A; Kerr DN
Proc Eur Dial Transplant Assoc; 1976; 12():397-402. PubMed ID: 935128
[TBL] [Abstract][Full Text] [Related]
6. Relationship between adiponectin, glycemic control and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease.
Jaleel F; Jaleel A; Aftab J; Rahman MA
Clin Chim Acta; 2006 Aug; 370(1-2):76-81. PubMed ID: 16516182
[TBL] [Abstract][Full Text] [Related]
7. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
8. Charcoal sorbent-induced hypolipidemia in uremia and diabetes.
Manis T; Deutsch J; Feinstein EI; Lum GY; Friedman EA
Am J Clin Nutr; 1980 Jul; 33(7):1485-8. PubMed ID: 6967252
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis.
Cattran DC; Steiner G; Fenton SS; Wilson DR
Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333
[No Abstract] [Full Text] [Related]
10. Oral sorbents in uremia: charcoal-induced reduction in plasma lipids.
Friedman EA
Am J Med; 1977 Apr; 62(4):541-2. PubMed ID: 851128
[No Abstract] [Full Text] [Related]
11. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?
Wasilewska A; Narkiewicz M; Rutkowski B; Łysiak-Szydłowska W
Med Sci Monit; 2003 Mar; 9(3):CR147-51. PubMed ID: 12640345
[TBL] [Abstract][Full Text] [Related]
12. Effect of bezafibrate on serum lipids in normo- and spontaneously hyperlipidemic rats.
Pill J; Wolff S; Stegmeier K; Schmidt FH
Methods Find Exp Clin Pharmacol; 1988 Aug; 10(8):487-92. PubMed ID: 3226219
[TBL] [Abstract][Full Text] [Related]
13. Clofibrate treatment of hyperlipidemia in chronic renal failure.
di Giulio S; Boulu R; Drüeke T; Nicolaĭ A; Zingraff J; Crosnier J
Clin Nephrol; 1977 Dec; 8(6):504-9. PubMed ID: 598055
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
15. Combined oxystarch-charcoal trial in uremia: sorbent-induced reduction in serum cholesterol.
Friedman EA; Saltzman MJ; Beyer MM; Josephson AS
Kidney Int Suppl; 1976 Dec; (7):S273-6. PubMed ID: 1070546
[No Abstract] [Full Text] [Related]
16. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
[TBL] [Abstract][Full Text] [Related]
17. Lipids in ischemic stroke subtypes.
Laloux P; Galanti L; Jamart J
Acta Neurol Belg; 2004 Mar; 104(1):13-9. PubMed ID: 15143957
[TBL] [Abstract][Full Text] [Related]
18. [Factors affecting serum lipid levels in patients with type 2 diabetes mellitus].
Tkác I; Tkácová R; Molcányiová A; Mudríková T; Takác M
Vnitr Lek; 1994 Jan; 40(1):17-20. PubMed ID: 8140744
[TBL] [Abstract][Full Text] [Related]
19. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
20. [Changes in lipid metabolism in patients with arteriosclerosis obliterans after charcoal hemoperfusion and hypolipidemic therapy in the preoperative period].
Burlakov SG; Diuzhikov AA; Beliavskiĭ VI; Golenko LA; Domnikova AA
Kardiologiia; 1992 Jan; 32(1):18-21. PubMed ID: 1614014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
